DNAJC19
Basic information
Region (hg38): 3:180983697-180989774
Links
Phenotypes
GenCC
Source:
- 3-methylglutaconic aciduria type 5 (Strong), mode of inheritance: AR
- 3-methylglutaconic aciduria type 5 (Supportive), mode of inheritance: AR
- 3-methylglutaconic aciduria type 5 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| 3-methylglutaconic aciduria, type V | AR | Cardiovascular | Individuals frequently demonstrate findings including cardiac manifestations such as dilated cardiomyopathy and dysrhythmias, and surveillance may allow early detection and management | Biochemical; Cardiovascular; Gastrointestinal; Genitourinary; Hematologic; Neurologic; Ophthalmologic | 16055927; 22981120 |
ClinVar
This is a list of variants' phenotypes submitted to
- 3-methylglutaconic_aciduria_type_5 (116 variants)
- not_provided (23 variants)
- Inborn_genetic_diseases (15 variants)
- not_specified (12 variants)
- DNAJC19-related_disorder (4 variants)
- 3-Methylglutaconic_aciduria (1 variants)
- 3-Methylglutaconic_aciduria_type_3 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJC19 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000145261.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 23 | 23 | ||||
| missense | 38 | 43 | ||||
| nonsense | 3 | |||||
| start loss | 2 | 2 | ||||
| frameshift | 12 | |||||
| splice donor/acceptor (+/-2bp) | 10 | |||||
| Total | 11 | 9 | 45 | 28 | 0 |
Highest pathogenic variant AF is 0.000041512492
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DNAJC19 | protein_coding | protein_coding | ENST00000382564 | 6 | 6066 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000613 | 0.741 | 125696 | 0 | 52 | 125748 | 0.000207 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.876 | 44 | 63.7 | 0.691 | 0.00000336 | 747 |
| Missense in Polyphen | 8 | 14.931 | 0.5358 | 197 | ||
| Synonymous | 0.152 | 18 | 18.8 | 0.955 | 9.07e-7 | 216 |
| Loss of Function | 0.934 | 6 | 9.03 | 0.664 | 5.47e-7 | 97 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000570 | 0.000570 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.000976 | 0.000971 |
| European (Non-Finnish) | 0.000123 | 0.000123 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner. May act as a co-chaperone that stimulate the ATP-dependent activity (By similarity). {ECO:0000250}.;
- Pathway
- Metabolism of proteins;Mitochondrial protein import
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.672
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.79
Haploinsufficiency Scores
- pHI
- 0.247
- hipred
- Y
- hipred_score
- 0.788
- ghis
- 0.648
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajc19
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- protein folding;protein targeting to mitochondrion;visual perception;protein import into mitochondrial matrix;positive regulation of ATPase activity;genitalia development
- Cellular component
- PAM complex, Tim23 associated import motor;mitochondrion;mitochondrial inner membrane;integral component of membrane;protein-containing complex
- Molecular function
- ATPase activator activity;protein binding;protein transporter activity